Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Conditions
Medulloblastoma Recurrent · Ependymoma Recurrent · ATRT Recurrent · Rare CNS Tumor Recurrent
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts, United States
Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
Contact: Study coordinator (Rebecca Loret de Mola) · rebecca.loretdemola@helendevoschildrens.org · 616-267-0334Contact: Principal Investigator (Rebecca Loret De Mola, MD)Dell Children's Medical Group SFC-HEM/ONC, Austin, Texas, United States
Contact: Principal Investigator (Virginia Harrod, MD)Medical University of Graz, Graz, Austria
Contact: Study coordinator (Elisabeth Hulla-Gumbsch) · elisabeth.hulla-gumbsch@klinikum-graz.at · +43 316 385Contact: Principal Investigator (Martin Benesch, MD)Medical University of Innsbruck, Innsbruck, Austria
Contact: Study coordinator (Yvonne Ennemoser, MSc) · yvonne.ennemoser@tirol-kliniken.at · +43 512 504Contact: Principal Investigator (Roman Crazzolara, MD)Kepler Universitätsklinikum Med Campus IV, Linz, Austria
Contact: Principal Investigator (Georg Ebetsberger, MD)Salzburger Universitätsklinikum, Salzburg, Austria
Contact: Principal Investigator (Agnes Gamper, MD)Medical University of Vienna, Vienna, Austria
Contact: Principal Investigator (Andreas Peyrl, MD)Irene Slavc, MD (Sub-investigator)University Hospital Brno, Brno, Czechia
Contact: Study coordinator (Alexandra Martincekova, MD) · Martincekova.Alexandra@fnbrno.cz · +420532234755Contact: Principal Investigator (Jaroslav Sterba, MD)Zdenek Pavelka, MD (Sub-investigator)Motol University Hospital Prague, Prague, Czechia
Contact: Principal Investigator (David Sumerauer, MD)University hospital Rigshospitalet, Copenhagen, Denmark
Contact: Principal Investigator (Karsten Nysom, MD)Centre Oscar Lambret, Lille, France
Centre Léon Bérard, Lyon, France
Contact: Principal Investigator (Pierre Leblond, MD)Onkologisk-hematologisk seksjon Barneklinikken Haukeland universitetssjukehus, Bergen, Norway
Contact: Principal Investigator (Ingrid Torsvik, MD)Hospital Infantil Universitario Nino Jesus, Madrid, Spain
Contact: Study coordinator (Alvaro Lassaletta, MD, PhD) · alvaro.lassaletta@salud.madrid.org · +34 915 035938Contact: Principal Investigator (Alvaro Lassaletta, MD, PhD)Sahlgrenska Universitetssjukhuset, Gothenburg, Sweden
Contact: Study coordinator (Anna Schröder- Håkansson) · anna.schroder_hakansson@vgregion.se · +46 31 343 58 65Contact: Principal Investigator (Magnus Sabel, MD)Birgitta Lannering, Prof (Sub-investigator)Universitetssjukhuset Linköping, Linköping, Sweden
Contact: Study coordinator (Birgitta Hellström) · birgitta.hellstrom@regionostergotland.se · +46 10 103 13 54Contact: Study coordinator (Pernilla Augustsson) · pernilla.augustsson@regionostergotland.se · +46 10-103 13 50Contact: Principal Investigator (Irene Devenney, MD)Skånes universitetssjukhus, Lund, Sweden
Contact: Principal Investigator (Helena Mörse, MD)Karolinska University Hospital, Stockholm, Sweden
Contact: Study coordinator (Yvonne Copeland) · yvonne.copeland-wahlo@karolinska.se · +46 8 517 724 84Contact: Principal Investigator (Stefan Holm, MD)Norrlands Universitetssjukhus, Umeå, Sweden
Contact: Study coordinator (Marita Wikström-Larsson) · Marita.Vikstrom.Larsson@vll.se · +46 90-785 02 44Contact: Principal Investigator (Mattias Mattsson)Akademiska sjukhuset, Uppsala, Sweden
Contact: Principal Investigator (Anders Öberg, MD)
Study leads
Andreas Peyrl, MD
Principal Investigator
Medical University of Vienna